2024 Rare Disease Diagnostics Report: Cost,Challenges and Patient Needs
- Insights | 24. 11. 21
Rare diseases impact millions of lives worldwide, yet the journey to diagnosis remains a significant challenge for patients and healthcare systems alike.
he 2024 Rare Disease Diagnostics Report sheds light on critical trends, barriers, and breakthroughs that are shaping the future of rare disease testing. This comprehensive report offers actionable insights for healthcare providers, researchers, and policymakers working to improve outcomes for rare disease patients.
In this article, we’ll explore few of the key findings from the report and discuss their implications for advancing rare disease diagnosis.
Key Findings from the 2024 Rare Disease Diagnostics Report
1. Whole Exome Sequencing (WES): The First Choice for Rare Disease Diagnosis
WES has emerged as the most widely adopted genetic testing method, with 70.8% of physicians citing it as their first-choice tool for diagnosing rare diseases.
2. Neurodevelopmental Disorders: The Most Common Rare Disease Diagnosed
Among rare diseases, neurodevelopmental disorders are the most frequently encountered, noted by 59.7% of surveyed physicians. This highlights the urgent need for specialized diagnostic approaches to address these conditions.
3. Financial Barriers: A Significant Challenge
Despite technological advancements, the cost of genetic testing remains a critical barrier. 77.8% of physicians identified financial obstacles as the primary issue limiting access to diagnostic tools, while 84.7% highlighted the high cost of testing as a major hurdle for patients.
Discover More in the Full Report
These findings only scratch the surface of the insights provided in the 2024 Rare Disease Diagnostics Report. The full report dives into:
• Groundbreaking strategies to reduce diagnostic costs and improve accessibility.
• Emerging technologies poised to revolutionize rare disease testing.
• Regional disparities in diagnostic availability and how they can be addressed.
• Practical, patient-centric solutions to enhance diagnostic outcomes.
Ready to explore these insights in depth?
Download the full report now to gain access to exclusive data and actionable solutions that can help reshape the future of rare disease diagnostics.
Download the 2024 Rare Disease Diagnostics Report Here
Together, we can break down barriers, transform diagnostic processes, and improve the lives of patients worldwide.
Do you find this post helpful?
Click the button below to copy and share the link.
Sree Ramya Gunukula
Marketing Leader with experience in the pharma and healthcare sectors, specializing in digital health, genetic testing, and rare disease diagnostics.